 New research suggesting a class of diabetes medications also used for weight loss, such as in Zempic, may lower the risk of some obesity-related cancers. Here's Michael Toscano. The study published in the Journal of the American Medical Association compared patients with type 2 diabetes and treated with insulin against patients taking the class of drugs which includes medications like Ozempic. The researchers report those who received the Ozempic class of drugs had a significantly lower risk of developing 10 out of 13 cancers studied.